{"id":10813,"date":"2022-01-28T12:28:38","date_gmt":"2022-01-28T12:28:38","guid":{"rendered":"http:\/\/cvx.vc\/?p=10813"},"modified":"2022-01-28T12:28:38","modified_gmt":"2022-01-28T12:28:38","slug":"perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden","status":"publish","type":"post","link":"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/","title":{"rendered":"Perfusion Tech underskriver term sheet med CVX Ventures: Har f\u00f8rste del af runden p\u00e5 plads"},"content":{"rendered":"\n<p>*<em>Hvis du er interesseret i at h\u00f8re mere om Perfusion Tech eller v\u00e6re med i CVX\u2019s investering, s\u00e5 kontakt venligst Investment Manager, Anders Larsen, p\u00e5 anders@cvx.vc<\/em>* Se Perfusion Tech&#8217;s pr\u00e6sentation til Presidents Summit <strong><em><a href=\"https:\/\/www.youtube.com\/watch?v=EEk3C_-AAvE\">her<\/a><\/em><\/strong>. <\/p>\n\n\n\n<p>MedTech-virksomheden Perfusion Tech g\u00f8r klar til at lukke en st\u00f8rre investeringsrunde gennem CVX Ventures med et fastsat term sheet.<\/p>\n\n\n\n<p>Perfusion Tech blev stiftet i 2016 af iv\u00e6rks\u00e6tterne Mads Agaard Madsen og Morten Lund med henblik p\u00e5 at \u00f8ge patientsikkerheden under operationer. Perfusion Tech har en patenteret software, som kan visualisere, analysere og kvantificere blodgennemstr\u00f8mningen i kroppens organer. V\u00e6kstvirksomheden er den f\u00f8rste til at kvantificere blodgennemstr\u00f8mningen i organer og kan tilkobles de systemer og arbejdsgange, der allerede eksisterer p\u00e5 operationsstuer.<\/p>\n\n\n\n<p><em>\u201cVi har p\u00e5 kort tid sammensat et st\u00e6rkt og engageret investorfelt. Sammen med det erfarne og st\u00e6rke management team samt eksisterende ejerkreds med st\u00e6rke resultater i baggagen, matcher de nye investorer Perfusion Tech&#8217;s ambitionsniveau. Produktet vil revolutionere bl\u00f8dningsrelaterede komplikationer ved kirurgiske indgreb, som sker ved 33% af operationer, og typisk fylder op mod halvdelen af operationstiden,\u201d<\/em> udtaler Anders Larsen, Investment Manager i CVX Ventures.<\/p>\n\n\n\n<p><em>\u201cMan regner med, at der er ca. to \u00e5r til exit-mulighed eller kommercielt partnerskab, med potentiale for at ramme en meget attraktiv exit-multipel, hvorfor ogs\u00e5 er \u00e5rsagen til, at vi har taget dem med i CVX Ventures,\u201d<\/em> udtaler Anders Larsen, Investment Manager i CVX Ventures.<\/p>\n\n\n\n<p><em>Hvis du er interesseret i at h\u00f8re mere om Perfusion Tech eller v\u00e6re med i CVX\u2019s investering, s\u00e5 kontakt venligst Investment Manager, Anders Larsen, p\u00e5 anders@cvx.vc<\/em> <\/p>\n\n\n\n<p>Se Perfusion Tech&#8217;s pr\u00e6sentation til Presidents Summit her.artnerm\u00f8de lige <strong><em><a href=\"https:\/\/www.youtube.com\/watch?v=EEk3C_-AAvE\">her<\/a><\/em><\/strong>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>MedTech-virksomheden Perfusion Tech g\u00f8r klar til at lukke en st\u00f8rre investeringsrunde gennem CVX Ventures med et fastsat term sheet. Perfusion Tech har en patenteret software, som kan visualisere, analysere og kvantificere blodgennemstr\u00f8mningen i kroppens organer.<\/p>\n","protected":false},"author":25,"featured_media":10814,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[18],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v22.4 (Yoast SEO v23.5) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Perfusion Tech underskriver term sheet med CVX Ventures: Har f\u00f8rste del af runden p\u00e5 plads | CVX Ventures<\/title>\n<meta name=\"description\" content=\"MedTech-virksomheden Perfusion Tech g\u00f8r klar til at lukke en st\u00f8rre investeringsrunde gennem CVX Ventures med et fastsat term sheet. Perfusion Tech har en patenteret software, som kan visualisere, analysere og kvantificere blodgennemstr\u00f8mningen i kroppens organer.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/\" \/>\n<meta property=\"og:locale\" content=\"da_DK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Perfusion Tech underskriver term sheet med CVX Ventures: Har f\u00f8rste del af runden p\u00e5 plads\" \/>\n<meta property=\"og:description\" content=\"MedTech-virksomheden Perfusion Tech g\u00f8r klar til at lukke en st\u00f8rre investeringsrunde gennem CVX Ventures med et fastsat term sheet. Perfusion Tech har en patenteret software, som kan visualisere, analysere og kvantificere blodgennemstr\u00f8mningen i kroppens organer.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/\" \/>\n<meta property=\"og:site_name\" content=\"CVX Ventures\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/cvxventures\/\" \/>\n<meta property=\"article:published_time\" content=\"2022-01-28T12:28:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/01\/Ugens-Virksomhed.png\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"400\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Kim Jessica Axholt\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Skrevet af\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kim Jessica Axholt\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimeret l\u00e6setid\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/\"},\"author\":{\"name\":\"Kim Jessica Axholt\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb\"},\"headline\":\"Perfusion Tech underskriver term sheet med CVX Ventures: Har f\u00f8rste del af runden p\u00e5 plads\",\"datePublished\":\"2022-01-28T12:28:38+00:00\",\"dateModified\":\"2022-01-28T12:28:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/\"},\"wordCount\":298,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cvx.vc\/da\/#organization\"},\"image\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/01\/Ugens-Virksomhed.png\",\"articleSection\":[\"Blogindl\u00e6g\"],\"inLanguage\":\"da-DK\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/\",\"url\":\"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/\",\"name\":\"Perfusion Tech underskriver term sheet med CVX Ventures: Har f\u00f8rste del af runden p\u00e5 plads | CVX Ventures\",\"isPartOf\":{\"@id\":\"https:\/\/cvx.vc\/da\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/01\/Ugens-Virksomhed.png\",\"datePublished\":\"2022-01-28T12:28:38+00:00\",\"dateModified\":\"2022-01-28T12:28:38+00:00\",\"description\":\"MedTech-virksomheden Perfusion Tech g\u00f8r klar til at lukke en st\u00f8rre investeringsrunde gennem CVX Ventures med et fastsat term sheet. Perfusion Tech har en patenteret software, som kan visualisere, analysere og kvantificere blodgennemstr\u00f8mningen i kroppens organer.\",\"breadcrumb\":{\"@id\":\"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/#breadcrumb\"},\"inLanguage\":\"da-DK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/#primaryimage\",\"url\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/01\/Ugens-Virksomhed.png\",\"contentUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/01\/Ugens-Virksomhed.png\",\"width\":800,\"height\":400},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hjem\",\"item\":\"https:\/\/cvx.vc\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Perfusion Tech underskriver term sheet med CVX Ventures: Har f\u00f8rste del af runden p\u00e5 plads\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cvx.vc\/da\/#website\",\"url\":\"https:\/\/cvx.vc\/da\/\",\"name\":\"CVX Ventures\",\"description\":\"Vi investerer i Danmarks mest lovende v\u00e6kstvirksomheder\",\"publisher\":{\"@id\":\"https:\/\/cvx.vc\/da\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cvx.vc\/da\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"da-DK\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cvx.vc\/da\/#organization\",\"name\":\"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor\",\"url\":\"https:\/\/cvx.vc\/da\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg\",\"contentUrl\":\"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg\",\"width\":827,\"height\":394,\"caption\":\"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor\"},\"image\":{\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/cvxventures\/\",\"https:\/\/www.linkedin.com\/company\/cvxventures\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb\",\"name\":\"Kim Jessica Axholt\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"da-DK\",\"@id\":\"https:\/\/cvx.vc\/da\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g\",\"caption\":\"Kim Jessica Axholt\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Perfusion Tech underskriver term sheet med CVX Ventures: Har f\u00f8rste del af runden p\u00e5 plads | CVX Ventures","description":"MedTech-virksomheden Perfusion Tech g\u00f8r klar til at lukke en st\u00f8rre investeringsrunde gennem CVX Ventures med et fastsat term sheet. Perfusion Tech har en patenteret software, som kan visualisere, analysere og kvantificere blodgennemstr\u00f8mningen i kroppens organer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/","og_locale":"da_DK","og_type":"article","og_title":"Perfusion Tech underskriver term sheet med CVX Ventures: Har f\u00f8rste del af runden p\u00e5 plads","og_description":"MedTech-virksomheden Perfusion Tech g\u00f8r klar til at lukke en st\u00f8rre investeringsrunde gennem CVX Ventures med et fastsat term sheet. Perfusion Tech har en patenteret software, som kan visualisere, analysere og kvantificere blodgennemstr\u00f8mningen i kroppens organer.","og_url":"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/","og_site_name":"CVX Ventures","article_publisher":"https:\/\/www.facebook.com\/cvxventures\/","article_published_time":"2022-01-28T12:28:38+00:00","og_image":[{"width":800,"height":400,"url":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/01\/Ugens-Virksomhed.png","type":"image\/png"}],"author":"Kim Jessica Axholt","twitter_card":"summary_large_image","twitter_misc":{"Skrevet af":"Kim Jessica Axholt","Estimeret l\u00e6setid":"2 minutter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/#article","isPartOf":{"@id":"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/"},"author":{"name":"Kim Jessica Axholt","@id":"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb"},"headline":"Perfusion Tech underskriver term sheet med CVX Ventures: Har f\u00f8rste del af runden p\u00e5 plads","datePublished":"2022-01-28T12:28:38+00:00","dateModified":"2022-01-28T12:28:38+00:00","mainEntityOfPage":{"@id":"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/"},"wordCount":298,"commentCount":0,"publisher":{"@id":"https:\/\/cvx.vc\/da\/#organization"},"image":{"@id":"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/#primaryimage"},"thumbnailUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/01\/Ugens-Virksomhed.png","articleSection":["Blogindl\u00e6g"],"inLanguage":"da-DK","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/","url":"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/","name":"Perfusion Tech underskriver term sheet med CVX Ventures: Har f\u00f8rste del af runden p\u00e5 plads | CVX Ventures","isPartOf":{"@id":"https:\/\/cvx.vc\/da\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/#primaryimage"},"image":{"@id":"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/#primaryimage"},"thumbnailUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/01\/Ugens-Virksomhed.png","datePublished":"2022-01-28T12:28:38+00:00","dateModified":"2022-01-28T12:28:38+00:00","description":"MedTech-virksomheden Perfusion Tech g\u00f8r klar til at lukke en st\u00f8rre investeringsrunde gennem CVX Ventures med et fastsat term sheet. Perfusion Tech har en patenteret software, som kan visualisere, analysere og kvantificere blodgennemstr\u00f8mningen i kroppens organer.","breadcrumb":{"@id":"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/#breadcrumb"},"inLanguage":"da-DK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/"]}]},{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/#primaryimage","url":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/01\/Ugens-Virksomhed.png","contentUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/01\/Ugens-Virksomhed.png","width":800,"height":400},{"@type":"BreadcrumbList","@id":"https:\/\/cvx.vc\/da\/insights\/perfusion-tech-underskriver-term-sheet-med-cvx-ventures-har-allerede-sikret-en-del-af-runden\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hjem","item":"https:\/\/cvx.vc\/"},{"@type":"ListItem","position":2,"name":"Perfusion Tech underskriver term sheet med CVX Ventures: Har f\u00f8rste del af runden p\u00e5 plads"}]},{"@type":"WebSite","@id":"https:\/\/cvx.vc\/da\/#website","url":"https:\/\/cvx.vc\/da\/","name":"CVX Ventures","description":"Vi investerer i Danmarks mest lovende v\u00e6kstvirksomheder","publisher":{"@id":"https:\/\/cvx.vc\/da\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cvx.vc\/da\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"da-DK"},{"@type":"Organization","@id":"https:\/\/cvx.vc\/da\/#organization","name":"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor","url":"https:\/\/cvx.vc\/da\/","logo":{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/","url":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg","contentUrl":"https:\/\/cvx.vc\/wp-content\/uploads\/2022\/08\/Group-241.svg","width":827,"height":394,"caption":"CVX Ventures | Danmarks mest v\u00e6rdiskabende investor"},"image":{"@id":"https:\/\/cvx.vc\/da\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/cvxventures\/","https:\/\/www.linkedin.com\/company\/cvxventures\/"]},{"@type":"Person","@id":"https:\/\/cvx.vc\/da\/#\/schema\/person\/4cbb55244c8f14962adcd709672339bb","name":"Kim Jessica Axholt","image":{"@type":"ImageObject","inLanguage":"da-DK","@id":"https:\/\/cvx.vc\/da\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/272190fb9f112ece965f1f17765feb31?s=96&d=mm&r=g","caption":"Kim Jessica Axholt"}}]}},"_links":{"self":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts\/10813"}],"collection":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/comments?post=10813"}],"version-history":[{"count":0,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/posts\/10813\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/media\/10814"}],"wp:attachment":[{"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/media?parent=10813"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/categories?post=10813"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cvx.vc\/da\/wp-json\/wp\/v2\/tags?post=10813"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}